StockNews.com Initiates Coverage on CytomX Therapeutics (NASDAQ:CTMX)

Equities researchers at StockNews.com initiated coverage on shares of CytomX Therapeutics (NASDAQ:CTMX – Get Free Report) in a report released on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock. Other research analysts have also issued research reports about the company. HC Wainwright reaffirmed a “neutral” rating on shares of CytomX Therapeutics […]